AlzeCure Pharma publishes its Annual Report for 2020

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that its Annual Report for 2020 has been published.

The Annual Report is attached as a PDF and is available on the company’s website,